CorMedix Inc.  

(Public, NYSEMKT:CRMD)   Watch this stock  
Find more results for CRMD
6.16
+0.66 (12.00%)
After Hours: 6.19 +0.03 (0.49%)
Mar 4, 7:03PM EST  
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 5.56 - 6.25
52 week 1.05 - 6.25
Open 5.95
Vol / Avg. 1.32M/666,556.00
Mkt cap 122.74M
P/E     -
Div/yield     -
EPS -1.17
Shares 22.38M
Beta -0.85
Inst. own 10%
Mar 10, 2015
CorMedix Inc at ROTH Conference - 3:30PM EDT - Add to calendar
Jan 12, 2015
CorMedix Inc at OneMedForum SF
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -9601.68% -456655.00%
Operating margin -8249.68% -318753.00%
EBITD margin - -245512.00%
Return on average assets -267.48% -443.24%
Return on average equity -1021.62% -
Employees 2 -
CDP Score - -

Address

745 Route 202-206, Suite 303
BRIDGEWATER, NJ 08807
United States - Map
+1-908-5179500 (Phone)
+1-908-4294307 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

CorMedix Inc. (CorMedix) is a development-stage specialty pharmaceutical company. The Company in-licenses, develops and commercializes therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases, specifically in the dialysis and non-dialysis areas. The Company has in-licensed all of the products in its pipeline. The company has the worldwide rights to develop and commercialize product candidates, CRMD003 (Neutrolin) and CRMD004, which address potentially large market opportunities in the instances in which a central venous catheter is used, such as hemodialysis, intensive care units, oncology and total parenteral nutrition patients.

Officers and directors

Randy Milby Chief Executive Officer, Director
Age: 61
Bio & Compensation  - Reuters
Antony E. Pfaffle M.D. Vice Chairman of the Board, Chief Scientific Officer
Age: 50
Bio & Compensation  - Reuters
Harry O'Grady Chief Financial Officer
Bio & Compensation  - Reuters
Matthew P. Duffy Independent Director
Age: 51
Bio & Compensation  - Reuters
Michael W. George Independent Director
Age: 65
Bio & Compensation  - Reuters
Steven W. Lefkowitz Independent Director
Age: 58
Bio & Compensation  - Reuters
Taunia S. Markvicka Pharm.D. Independent Director
Age: 45
Bio & Compensation  - Reuters
Cora M. Tellez Independent Director
Bio & Compensation  - Reuters